Discovery Pipeline

Aug 23, 2017
By BioPharm International Editors
AstraZeneca and Champions will develop new cohorts of patient-derived xenograft models to be used in oncology programs in breast and lung cancer as well as for use in other academic and industry applications.
May 08, 2017
Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.
Feb 14, 2017
Evaluate and BioPharm International highlight the antibody-based therapeutics that may have 2017 launch dates in the United States.
Feb 13, 2017
EvaluatePharma and BioPharm International highlight the antibody-based therapeutics that may gain United States Regulatory approval in 2017.
Jan 28, 2016
BioPharm International
The body’s over-editing of synaptic interactions is recognized as a probable cause of schizophrenia in a landmark study.
Sep 25, 2015
By BioPharm International Editors
MedImmune and 3M Drug Delivery Systems collaborate to develop toll-like receptor (TLR) agonists for immuno-oncology.
Jun 18, 2015
By BioPharm International Editors
GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.
Mar 17, 2015
BioPharm International
Treatment with monoclonal antibodies that inhibit the activity of PCSK9 was shown to significantly lower LDL cholesterol levels and have a strong cardiovascular benefit.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Feb 20, 2015
BioPharm International
MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.
lorem ipsum